Last reviewed · How we verify
Bronchospasm Prevention with COPD
Approved treatments
- Cutivate · Teva Pharm
- Foradil · Novartis
Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing. - Spiriva · Boehringer Ingelheim
Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways. - Flonase · GSK (GlaxoSmithKline)
- Arcapta Neohaler · Novartis
- Flixotide · Mundipharma Research Limited
- Fluticason · Creighton University
- Serevent · Fundacio Privada Mon Clinic Barcelona
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bronchospasm Prevention with COPD patent landscape — cliff calendar, originator estates, attackable patents
- Bronchospasm Prevention with COPD treatment landscape brief
- Bronchospasm Prevention with COPD treatment updates RSS
Frequently asked questions about Bronchospasm Prevention with COPD
What drugs treat Bronchospasm Prevention with COPD?
Tracked treatments include Cutivate, Foradil, Spiriva, Flonase, Arcapta Neohaler, Flixotide, Fluticason, Serevent.
What is the treatment for Bronchospasm Prevention with COPD?
Standard treatment for Bronchospasm Prevention with COPD includes Cutivate, Foradil, Spiriva, Flonase, Arcapta Neohaler. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bronchospasm Prevention with COPD patent cliff · Bronchospasm Prevention with COPD CI report
- Treatment: Cutivate · Teva Pharm
- Treatment: Foradil · Novartis
- Treatment: Spiriva · Boehringer Ingelheim
- Treatment: Flonase · GSK (GlaxoSmithKline)
- Treatment: Arcapta Neohaler · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing